Overview of the Side-Effects of FDA- and/or EMA-Approved Targeted Therapies for the Treatment of Hematological Malignancies
Constantinescu, C.; Pasca, S.; Zimta, A.-A.; Tat, T.; Rus, I.; Teodorescu, P.; Iluta, S.; Tanase, A.; Colita, A.; Sigurjonsson, O.; Einsele, H.; Tomuleasa, C. Overview of the Side-Effects of FDA- and/or EMA-Approved Targeted Therapies for the Treatment of Hematological Malignancies. J. Clin. Med. 2020, 9, 2903. https://doi.org/10.3390/jcm9092903
Constantinescu C, Pasca S, Zimta A-A, Tat T, Rus I, Teodorescu P, Iluta S, Tanase A, Colita A, Sigurjonsson O, Einsele H, Tomuleasa C. Overview of the Side-Effects of FDA- and/or EMA-Approved Targeted Therapies for the Treatment of Hematological Malignancies. Journal of Clinical Medicine. 2020; 9(9):2903. https://doi.org/10.3390/jcm9092903
Chicago/Turabian StyleConstantinescu, Catalin, Sergiu Pasca, Alina-Andreea Zimta, Tiberiu Tat, Ioana Rus, Patric Teodorescu, Sabina Iluta, Alina Tanase, Anca Colita, Olafur Sigurjonsson, Hermann Einsele, and Ciprian Tomuleasa. 2020. "Overview of the Side-Effects of FDA- and/or EMA-Approved Targeted Therapies for the Treatment of Hematological Malignancies" Journal of Clinical Medicine 9, no. 9: 2903. https://doi.org/10.3390/jcm9092903